Agency Forms Undergoing Paperwork Reduction Act Review, 47173-47174 [2018-20245]
Download as PDF
<![CDATA[
47173
Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form name
U.S. General Population .................................
Landline Screener ..........................................
Cell Phone Screener ......................................
Field Test Screener ........................................
BRFSS Core Survey ......................................
BRFSS Optional Modules ..............................
Field Test Survey ...........................................
Annual Survey Respondents (Adults >18
Years).
Field Test Respondents (Adults >18 Years) ..
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–20248 Filed 9–17–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0840]
daltland on DSKBBV9HB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Formative
Research and Tool Development’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on April 23, 2018 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
19:14 Sep 17, 2018
Jkt 244001
Number of
respondents
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Formative Research and Tool
Development (OMB Control No. 0920–
0840, Expiration 1/31/2019)—
Extension—National Center for HIV/
AIDS, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention, National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP) requests
approval for an extension and a three
year approval for the previously
approved Generic Clearance,
‘‘Formative Research and Tool
Development’’. This information
collection request is designed to allow
NCHHSTP to conduct formative
research information collection
activities used to inform many aspects
of surveillance, communications, health
promotion, and research project
development for NCHHSTP’s four
priority diseases (HIV/AIDS, sexually
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
375,000
292,682
900
480,000
440,000
500
Number of
responses per
respondent
1
1
1
1
1
1
Average
burden per
response
(in hours)
1/60
1/60
1/60
15/60
15/60
45/60
transmitted diseases/infections (STD/
STI), viral hepatitis, tuberculosis
elimination and the Division of School
and Adolescent Heath (DASH).
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics/interests, behaviors and
needs of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs, as well as
improving existing and ongoing
programs. Formative research also looks
at the community in which a public
health intervention is being or will be
implemented, and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research is research that occurs before a
program is designed and implemented,
or while a program is being conducted.
NCHHSTP formative research is
necessary for developing new programs
or adapting programs that deal with the
complexity of behaviors, social context,
cultural identities, and health care that
underlie the epidemiology of HIV/AIDS,
viral hepatitis, STDs, and TB in the U.S,
as well as for school and adolescent
health. CDC conducts formative
research to develop public-sensitive
communication messages and user
friendly tools prior to developing or
recommending interventions, or care.
Sometimes these studies are entirely
behavioral but most often they are
cycles of interviews and focus groups
designed to inform the development of
a product.
Products from these formative
research studies will be used for
prevention of HIV/AIDS, Sexually
Transmitted Infections (STI), viral
Hepatitis, and Tuberculosis. Findings
from these studies may also be
presented as evidence to diseasespecific National Advisory Committees,
to support revisions to recommended
prevention and intervention methods, as
well as new recommendations.
E:\FR\FM\18SEN1.SGM
18SEN1
47174
Federal Register / Vol. 83, No. 181 / Tuesday, September 18, 2018 / Notices
Much of CDC’s health communication
takes place within campaigns that have
fairly lengthy planning periods—
timeframes that accommodate the
standard Federal process for approving
data collections. Short term qualitative
interviewing and cognitive research
techniques have previously proven
invaluable in the development of
scientifically valid and populationappropriate methods, interventions, and
instruments.
This request includes studies
investigating the utility and
acceptability of proposed sampling and
recruitment methods, intervention
contents and delivery, questionnaire
domains, individual questions, and
interactions with project staff or
electronic data collection equipment.
These activities will also provide
information about how respondents
answer questions and ways in which
question response bias and error can be
reduced. This request also includes
collection of information from public
health programs to assess needs related
to initiation of a new program activity,
or expansion or changes in scope, or
implementation of existing program
activities to adapt them to current
needs. The information collected will be
used to advise programs and provide
capacity-building assistance tailored to
identified needs.
Overall, these development activities
are intended to provide information that
will increase the success of the
surveillance or research projects
through increasing response rates and
decreasing response error, thereby
decreasing future data collection burden
to the public. The studies that will be
covered under this request will include
one or more of the following
investigational modalities: (1)
Structured and qualitative interviewing
for surveillance, research, interventions
and material development, (2) cognitive
interviewing for development of specific
data collection instruments, (3)
methodological research, (4) usability
testing of technology-based instruments
and materials, (5) field testing of new
methodologies and materials, (6)
investigation of mental models for
health decision-making, to inform
health communication messages, and (7)
organizational needs assessments to
support development of capacity.
Respondents who will participate in
individual and group interviews
(qualitative, cognitive, and computer
assisted development activities) are
selected purposively from those who
respond to recruitment advertisements.
In addition to utilizing advertisements
for recruitment, respondents who will
participate in research on survey
methods may be selected purposively or
systematically from within an ongoing
surveillance or research project. The
total burden hours for this collection is
46,516. Participation of respondents is
voluntary. There is no cost to
participants other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
General public .................................................
Health care providers ......................................
General public .................................................
Health care providers ......................................
General public .................................................
Health care providers ......................................
General public .................................................
Health care providers ......................................
General public .................................................
Health care providers ......................................
Screener .........................................................
Screener .........................................................
Consent Forms ...............................................
Consent Forms ...............................................
Individual Interview .........................................
Individual Interview .........................................
Focus Group Interview ...................................
Focus Group Interview ...................................
Survey of Individual ........................................
Survey of Individual ........................................
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–20245 Filed 9–17–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[CDC–2016–0001; Docket Number NIOSH
260–A]
Revised Draft NIOSH Current
Intelligence Bulletin: Health Effects of
Occupational Exposure to Silver
Nanomaterials
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
AGENCY:
VerDate Sep<11>2014
19:14 Sep 17, 2018
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of draft document
available for public comment and online
public meeting.
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following draft document for public
comment titled Current Intelligence
Bulletin: Health Effects of Occupational
Exposure to Silver Nanomaterials. To
view the notice, document and related
materials, visit https://
www.regulations.gov and enter CDC–
2016–0001 in the search field and click
‘‘Search’’.
DATES: The public online meeting will
be held on October 30, 2018, 1 p.m.–
4:30 p.m., Eastern Time, or until the last
public commenter has spoken,
SUMMARY:
BILLING CODE 4163–18–P
daltland on DSKBBV9HB2PROD with NOTICES
Number of
respondents
Type of respondent
Jkt 244001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
56,840
24,360
28,420
12,180
4,620
1,980
2,800
1,200
21,000
9,000
Number of
responses per
respondent
Average hours
per response
1
1
1
1
1
1
1
1
1
1
10/60
10/60
5/60
5/60
1
1
2
2
30/60
30/60
whichever occurs first. The public
online meeting will be a web-based
event available only by remote access.
Members of the public who wish to
provide public comments should plan
to login to the meeting at the start time
listed. Members of the public who
register with the NIOSH Docket Office,
niocindocket@cdc.gov to attend the
public meeting will be provided the
login information prior to the meeting.
ADDRESSES: Written comments
submitted to the docket must be
received by November 30, 2018. Written
comments may be submitted by either of
the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: NIOSH Docket Office, 1090
Tusculum Avenue, MS C–34,
Cincinnati, Ohio 45226–1998.
FOR FURTHER INFORMATION CONTACT:
Charles Geraci, NIOSH/EID/NTRC,
Robert A. Taft Laboratories, 1090
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 83, Number 181 (Tuesday, September 18, 2018)]
[Notices]
[Pages 47173-47174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-20245]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-0840]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Formative Research and Tool Development''
to the Office of Management and Budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on April 23, 2018 to obtain
comments from the public and affected agencies. CDC received one
comment related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Formative Research and Tool Development (OMB Control No. 0920-0840,
Expiration 1/31/2019)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention, National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) requests
approval for an extension and a three year approval for the previously
approved Generic Clearance, ``Formative Research and Tool
Development''. This information collection request is designed to allow
NCHHSTP to conduct formative research information collection activities
used to inform many aspects of surveillance, communications, health
promotion, and research project development for NCHHSTP's four priority
diseases (HIV/AIDS, sexually transmitted diseases/infections (STD/STI),
viral hepatitis, tuberculosis elimination and the Division of School
and Adolescent Heath (DASH). Formative research is the basis for
developing effective strategies including communication channels, for
influencing behavior change. It helps researchers identify and
understand the characteristics/interests, behaviors and needs of target
populations that influence their decisions and actions.
Formative research is integral in developing programs, as well as
improving existing and ongoing programs. Formative research also looks
at the community in which a public health intervention is being or will
be implemented, and helps the project staff understand the interests,
attributes and needs of different populations and persons in that
community. Formative research is research that occurs before a program
is designed and implemented, or while a program is being conducted.
NCHHSTP formative research is necessary for developing new programs or
adapting programs that deal with the complexity of behaviors, social
context, cultural identities, and health care that underlie the
epidemiology of HIV/AIDS, viral hepatitis, STDs, and TB in the U.S, as
well as for school and adolescent health. CDC conducts formative
research to develop public-sensitive communication messages and user
friendly tools prior to developing or recommending interventions, or
care. Sometimes these studies are entirely behavioral but most often
they are cycles of interviews and focus groups designed to inform the
development of a product.
Products from these formative research studies will be used for
prevention of HIV/AIDS, Sexually Transmitted Infections (STI), viral
Hepatitis, and Tuberculosis. Findings from these studies may also be
presented as evidence to disease-specific National Advisory Committees,
to support revisions to recommended prevention and intervention
methods, as well as new recommendations.
[[Page 47174]]
Much of CDC's health communication takes place within campaigns
that have fairly lengthy planning periods-- timeframes that accommodate
the standard Federal process for approving data collections. Short term
qualitative interviewing and cognitive research techniques have
previously proven invaluable in the development of scientifically valid
and population-appropriate methods, interventions, and instruments.
This request includes studies investigating the utility and
acceptability of proposed sampling and recruitment methods,
intervention contents and delivery, questionnaire domains, individual
questions, and interactions with project staff or electronic data
collection equipment. These activities will also provide information
about how respondents answer questions and ways in which question
response bias and error can be reduced. This request also includes
collection of information from public health programs to assess needs
related to initiation of a new program activity, or expansion or
changes in scope, or implementation of existing program activities to
adapt them to current needs. The information collected will be used to
advise programs and provide capacity-building assistance tailored to
identified needs.
Overall, these development activities are intended to provide
information that will increase the success of the surveillance or
research projects through increasing response rates and decreasing
response error, thereby decreasing future data collection burden to the
public. The studies that will be covered under this request will
include one or more of the following investigational modalities: (1)
Structured and qualitative interviewing for surveillance, research,
interventions and material development, (2) cognitive interviewing for
development of specific data collection instruments, (3) methodological
research, (4) usability testing of technology-based instruments and
materials, (5) field testing of new methodologies and materials, (6)
investigation of mental models for health decision-making, to inform
health communication messages, and (7) organizational needs assessments
to support development of capacity.
Respondents who will participate in individual and group interviews
(qualitative, cognitive, and computer assisted development activities)
are selected purposively from those who respond to recruitment
advertisements. In addition to utilizing advertisements for
recruitment, respondents who will participate in research on survey
methods may be selected purposively or systematically from within an
ongoing surveillance or research project. The total burden hours for
this collection is 46,516. Participation of respondents is voluntary.
There is no cost to participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
General public........................ Screener................ 56,840 1 10/60
Health care providers................. Screener................ 24,360 1 10/60
General public........................ Consent Forms........... 28,420 1 5/60
Health care providers................. Consent Forms........... 12,180 1 5/60
General public........................ Individual Interview.... 4,620 1 1
Health care providers................. Individual Interview.... 1,980 1 1
General public........................ Focus Group Interview... 2,800 1 2
Health care providers................. Focus Group Interview... 1,200 1 2
General public........................ Survey of Individual.... 21,000 1 30/60
Health care providers................. Survey of Individual.... 9,000 1 30/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-20245 Filed 9-17-18; 8:45 am]
BILLING CODE 4163-18-P
